The Medicare GLP-1 Bridge is a short-term demonstration run by the Centers for Medicare & Medicaid Services (CMS) that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027
Report tremors, palpitations, or worsening anxiety to your doctor immediatelythese could signal thyroid imbalance
Side Effects Both forms share similar semaglutide side effects, primarily gastrointestinal symptoms including nausea (46.6%), vomiting (30.9%), and constipation (20.1%)
doi: 10.1016/j.advms.2017.05.005 20 SenguptaPDuttaSSlamaPRoychoudhuryS
Semaglutide may cause anxiety, bloating, blurry vision, chest tightness, chills, and constipation, Dr